Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference. A Gasbarrini, GR Corazza, G Gasbarrini, M Montalto, M Di Stefano, ... Alimentary pharmacology & therapeutics 29, 1-49, 2009 | 561 | 2009 |
Pegylated interferon alpha‐2b as monotherapy or in combination with ribavirin in chronic hepatitis delta GA Niro, A Ciancio, GB Gaeta, A Smedile, A Marrone, A Olivero, ... Hepatology 44 (3), 713-720, 2006 | 293 | 2006 |
Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial A Andriulli, R Clemente, L Solmi, V Terruzzi, R Suriani, A Sigillito, ... Gastrointestinal endoscopy 56 (4), 488-495, 2002 | 293 | 2002 |
Genome search in celiac disease L Greco, G Corazza, MC Babron, F Clot, MC Fulchignoni-Lataud, ... The American Journal of Human Genetics 62 (3), 669-675, 1998 | 286 | 1998 |
Peginterferon alfa-2b and ribavirin in patients with hepatitis C virus and decompensated cirrhosis: a controlled study A Iacobellis, M Siciliano, F Perri, BE Annicchiarico, G Leandro, N Caruso, ... Journal of hepatology 46 (2), 206-212, 2007 | 273 | 2007 |
Controlled trial of botulinum toxin injection versus placebo and pneumatic dilation in achalasia V Annese, M Basciani, F Perri, G Lombardi, V Frusciante, P Simone, ... Gastroenterology 111 (6), 1418-1424, 1996 | 252 | 1996 |
Randomized study of two “rescue” therapies forHelicobacter pylori-infected patients after failure of standard triple therapies F Perri, V Festa, R Clemente, MR Villani, M Quitadamo, N Caruso, ... Official journal of the American College of Gastroenterology| ACG 96 (1), 58-62, 2001 | 246 | 2001 |
Aberrant DNA methylation in non-neoplastic gastric mucosa of H. pylori infected patients and effect of eradication F Perri, R Cotugno, A Piepoli, A Merla, M Quitadamo, A Gentile, A Pilotto, ... Official journal of the American College of Gastroenterology| ACG 102 (7 …, 2007 | 241 | 2007 |
Meta‐analysis of somatostatin, octreotide and gabexate mesilate in the therapy of acute pancreatitis Andriulli, Leandro, Clemente, Festa, N Caruso, Annese, Lezzi, Lichino, ... Alimentary pharmacology & therapeutics 12 (3), 237-245, 1998 | 222 | 1998 |
Patterns of symptoms in functional dyspepsia: role ofHelicobacter pyloriinfection and delayed gastric emptying F Perri, R Clemente, V Festa, V Annese, M Quitadamo, P Rutgeerts, ... Official journal of the American College of Gastroenterology| ACG 93 (11 …, 1998 | 216 | 1998 |
Rifabutin‐based ‘rescue therapy’ for Helicobacter pylori infected patients after failure of standard regimens Perri, Festa, Clemente, Quitadamo, Andriulli Alimentary pharmacology & therapeutics 14 (3), 311-316, 2000 | 179 | 2000 |
Helicobacter pylori infection and growth delay in older children F Perri, M Pastore, G Leandro, R Clemente, Y Ghoos, M Peeters, ... Archives of disease in childhood 77 (1), 46-49, 1997 | 172 | 1997 |
Clinical features of reflux esophagitis in older people: a study of 840 consecutive patients A Pilotto, M Franceschi, G Leandro, C Scarcelli, LP D'Ambrosio, D Seripa, ... Journal of the American Geriatrics Society 54 (10), 1537-1542, 2006 | 169 | 2006 |
Prophylaxis of ERCP-related pancreatitis: a randomized, controlled trial of somatostatin and gabexate mesylate A Andriulli, L Solmi, S Loperfido, P Leo, V Festa, A Belmonte, F Spirito, ... Clinical Gastroenterology and Hepatology 2 (8), 713-718, 2004 | 162 | 2004 |
Epigenetic control of gene expression: Potential implications for cancer treatment F Perri, F Longo, M Giuliano, F Sabbatino, G Favia, F Ionna, R Addeo, ... Critical reviews in oncology/hematology 111, 166-172, 2017 | 149 | 2017 |
Predictors of failure of Helicobacter pylori eradication with the standard ‘Maastricht triple therapy’ F Perri, MR Villani, V Festa, M Quitadamo, A Andriulli Alimentary pharmacology & therapeutics 15 (7), 1023-1029, 2001 | 148 | 2001 |
1st Rome H2-Breath Testing Consensus Conference Working Group. Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference. A Gasbarrini, GR Corazza, G Gasbarrini, M Montalto, M Di Stefano, ... Alimentary Pharmacology & Therapeutics 29 (1), 1-49, 2009 | 144 | 2009 |
Variants of CARD15 are associated with an aggressive clinical course of Crohn's disease—an IG-IBD study V Annese, G Lombardi, F Perri, R D'incà, S Ardizzone, G Riegler, ... Official journal of the American College of Gastroenterology| ACG 100 (1), 84-92, 2005 | 138 | 2005 |
Lamivudine therapy in chronic delta hepatitis: a multicentre randomized‐controlled pilot study GA Niro, A Ciancio, HL Tillman, M Lagget, A Olivero, F Perri, R Fontana, ... Alimentary pharmacology & therapeutics 22 (3), 227-232, 2005 | 133 | 2005 |
High-versus low-dose proton pump inhibitors after endoscopic hemostasis in patients with peptic ulcer bleeding: a multicentre, randomized study A Andriulli, S Loperfido, R Focareta, P Leo, F Fornari, A Garripoli, P Tonti, ... Official journal of the American College of Gastroenterology| ACG 103 (12 …, 2008 | 130 | 2008 |